Your browser doesn't support javascript.
loading
Clinical and economic evaluation of blood culture whole process optimisation in critically ill adult patients with positive blood cultures.
Dai, Yuanyuan; Zhu, Xiongfeng; Chang, Wenjiao; Lu, Huaiwei; Nie, Zhengchao; Wu, Yongqin; Yao, Haifeng; Chen, Yunbo; Xiao, Yonghong; Chu, Xinmin.
Affiliation
  • Dai Y; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Zhu X; Department of Critical Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Chang W; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Lu H; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Nie Z; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Wu Y; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Yao H; Department of Information Center, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Chen Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of Chi
  • Xiao Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of Chi
  • Chu X; Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China. Electronic address: chuxm0211@163.com.
Int J Antimicrob Agents ; 63(6): 107176, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38642811
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Blood Culture / Intensive Care Units / Anti-Bacterial Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Antimicrob Agents Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Blood Culture / Intensive Care Units / Anti-Bacterial Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Antimicrob Agents Year: 2024 Document type: Article Country of publication: